CVLT Form 144: 14,909 Shares Proposed Sale; Prior 11,151-Share Sale
Rhea-AI Filing Summary
Form 144 notice for Commvault Systems, Inc. (CVLT): The filer reports a proposed sale of 14,909 common shares through Morgan Stanley Smith Barney on 09/09/2025 on NASDAQ, with an aggregate market value of $2,716,729.91. These shares were acquired on 08/15/2025 from the issuer as 4,744 performance shares and 10,165 restricted stock. The filing also discloses a recent sale by Jennifer Dirico of 11,151 common shares on 08/18/2025 for gross proceeds of $1,985,264.94. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Positive
- Clear disclosure of planned sale details: shares, broker, date, and market value
- Acquisitions identified as performance shares and restricted stock with specific unit counts
Negative
- Recent insider sales are sizable: 11,151 shares sold on 08/18/2025 for $1,985,264.94
- Planned sale market value is material at $2,716,729.91, which may raise investor questions about insider liquidity
Insights
TL;DR: Routine insider filing disclosing planned sale of newly issued shares and a recent sizable disposition; likely neutral to modestly negative for optics.
This Form 144 documents a planned sale of 14,909 shares (market value $2.72M) acquired on 08/15/2025 as compensation (performance and restricted stock). The filing gives investors visibility into insider liquidity and recent insider activity, including a prior sale of 11,151 shares for $1.99M on 08/18/2025. From a market-impact perspective, disclosure is timely and complete for a Rule 144 transaction; however, two relatively large insider dispositions in short succession may draw investor attention. There is no earnings or operational data in the filing to change valuation models.
TL;DR: Governance disclosure appears compliant; transactions are identified as issuer-granted equity being sold under Rule 144.
The filing indicates shares were granted by the issuer on 08/15/2025 and are being sold under Rule 144 through a broker-dealer, which aligns with standard post-vesting disposition processes. The representation concerning absence of undisclosed material information is present. There is no indication of a 10b5-1 plan date or other restrictive note in the remarks, so oversight of timing and insider trading policies may be relevant for governance review. No regulatory or litigation concerns are disclosed.
AI-generated analysis. How Rhea-AI works. Not financial advice.